查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008876

核子醫學設備市場報告：按產品、應用、最終用戶和地區分類（2026-2034 年）

Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球核醫設備市場規模達34億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到56億美元，2026年至2034年的複合年成長率（CAGR）為5.34%。市場成長顯著主要得益於對慢性疾病治療和早期診斷需求的不斷成長。此外，診斷影像技術的創新以及新興市場和已開發國家對醫療保健領域（尤其是腫瘤學和神經病學領域）投資的增加，也進一步推動了市場的擴張。

核子醫學設備市場趨勢：

混合成像系統應用範圍擴大

全球核子醫學設備市場的一個顯著趨勢是混合影像解決方案（例如SPECT和PET）的日益普及。根據業界報告顯示，2024年2月，印度PGIMER開發了一種先進的基於PET/CT的切片檢查方法，該方法在診斷前列腺癌方面取得了95%的成功率。此類先進技術結合了解剖成像和功能成像，提高了心血管疾病和癌症等複雜疾病的診斷準確性。此外，這些系統的引入使醫療專業人員能夠更準確地監測疾病進展，從而製定更有效的治療策略。這種混合系統的發展趨勢也凸顯了對先進診斷工具日益成長的需求，推動了市場成長，並刺激了成像技術領域的進一步研發活動。

分子成像應用的擴展

根據核醫設備市場研究報告，分子影像技術在全球市場正迅速發展。這一趨勢主要歸功於該技術能夠對分子和細胞活動進行詳細分析，有助於疾病的早期發現，尤其是在循環系統、腫瘤和神經系統疾病領域。此外，分子成像技術能夠實現更精準的診斷，並支持整體的個人化治療方法。例如，2024年2月，北美放射學會（RSNA）的研究人員開發了一種分子成像技術，在乳癌檢測中具有高靈敏度，同時降低了假陽性率。具體而言，該技術的假陽性率僅16%，而MRI的偽陽性率則高達62%。此外，隨著用於這些檢測的放射性藥物的效率不斷提高，預計對分子成像的需求將大幅成長，並成為重要的市場趨勢。

擴大放射性藥物的使用範圍。

根據《核子醫學設備市場報告》，放射性藥物的日益普及是全球市場的主要趨勢之一。放射性藥物在治療和診斷應用中發揮著至關重要的作用，尤其是在某些慢性疾病和癌症的治療中。此外，放射性藥物研發的創新，例如減少副作用和增強標靶化，正在提高核醫學治療和影像的有效性。同時，醫療專業人員現在在治療和診斷過程中依賴這些化合物，從而導致對能夠高效利用這些先進藥物的核醫學設備的需求不斷成長。例如，2024年8月，領先的製藥公司禮來宣布將業務拓展至核同位素生產領域，以確保腫瘤治療所需的放射性化合物的穩定供應。作為擴大策略的一部分，該公司向同位素供應商Ionetics投資了1000萬美元。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球核子醫學設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 單光子發射電腦斷層掃描
    • 主要部分
      • 獨立版
      • 混合
  • 正子斷層掃描
    • 主要部分
      • 獨立版
      • 混合
  • 平面閃爍顯像

第7章 市場區隔：依應用領域分類

  • 神經病學
  • 腫瘤學
  • 循環系統
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷影像中心
  • 學術研究機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Biodex Medical Systems Inc.（Mirion Technologies Inc.）
    • Cardinal Health Inc.
    • CMR Naviscan Corporation
    • DDD-Diagnostic A/S
    • Digirad Corporation
    • General Electric Company
    • Koninklijke Philips NV
    • Mediso Ltd.
    • Neusoft Corporation
    • Siemens AG
    • SurgicEye GmbH
    • Toshiba Corporation
Product Code: SR112026A4598

The global nuclear medicine equipment market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.34% during 2026-2034. The market is witnessing significant growth due to the increasing need for chronic diseases treatment and early diagnosis. Moreover, innovations in imaging technologies and heightening investments in healthcare sector, especially in oncology and neurology applications across both emerging and developed region, is further expanding the market.

NUCLEAR MEDICINE EQUIPMENT MARKET ANALYSIS:

  • Major Market Drivers: The market is principally driven by the magnifying prevalence of chronic disorders, such as cardiovascular disease and cancer, which demand upgraded treatment and diagnostic solutions. Moreover, rising demand for personalized treatment methods ad early disease detection, combined with technological innovations in imaging techniques, is fueling market expansion. In addition, developing healthcare infrastructure and elevating healthcare expenditure in developing as well as developed countries further foster the market's development. Furthermore, increasing awareness regarding the potential of nuclear medicine equipment, in enhancing patient outcomes has resulted to its amplified adoption across medical sector, establishing a profitable environment for the nuclear medicine equipment market growth.
  • Key Market Trends: Some of the key trends include technological advancements in imaging techniques and the intensifying adoption of hybrid imaging solutions. The incorporation of single photon emission computed tomography (SPECT) and positron emission tomography (PET) systems has improved the accuracy of diagnostic imaging, resulting in an enhanced treatment strategy and disease detection. Moreover, the market is also experiencing heightened research and development activities aimed at minimizing radiation exposure and improving imaging abilities. In addition, the magnifying emphasis on molecular imaging, combined with the innovation of advanced radioisotopes, is supporting the healthcare professionals in diagnosing diseases more precisely, further increasing the medicine equipment market demand significantly.
  • Geographical Trends: North America has emerged as the dominant region in the global nuclear medicine equipment market, mainly driven by resilient healthcare infrastructure and cutting-edge technology adoption. The United States, in particular, is a major contributor, with an elevated demand for nuclear imaging due to an increasing prevalence of chronic disorders and amplifying healthcare expenditure. Moreover, accelerating awareness regarding the benefits of nuclear medicine among patients as well as healthcare providers is significantly bolstering its adoption across numerous medical applications in the region. In addition, government campaigns endorsing research in nuclear medicine, along with the presence of key market players, further elevates the medicine equipment market value in North America.
  • Competitive Landscape: Some of the major market players in the nuclear medicine equipment industry include Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH, Toshiba Corporation, among many others.
  • Challenges and Opportunities: The market experiences challenges, such as strict regulatory standards and elevated equipment costs. The demand for trained and skilled personnels to operate sophisticated imaging equipment supplements operational challenges. However, there are substantial growth opportunities observed in developing countries with growing healthcare infrastructure and increasing investment in medical technologies. Moreover, innovations in radiopharmaceuticals and cost-effective imaging solutions further increase market prospects, establishing profitable opportunities for nuclear medicine equipment market expansion.

NUCLEAR MEDICINE EQUIPMENT MARKET TRENDS:

Increasing Adoption of Hybrid Imaging Systems

A notable trend in the global nuclear equipment market is the increasing adoption of hybrid imaging solutions such as SPECT and PET. As per industry reports, in February 2024, PGIMER, India, developed a cutting-edge PET/CT-based biopsy that exhibited 95% success rate for prostate cancer diagnosis. Such advanced technologies blend anatomical and functional imaging, offering improved precision in diagnosing complicated diseases such as cardiovascular disorders and cancer. In addition, the incorporation of such systems allows healthcare professionals to better monitor the progression of disease, resulting in a more efficient treatment strategy. Moreover, this inclination towards hybrid systems highlights the fueling demand for upgraded diagnostics tools, spurring market growth and fostering further research and development activities in imaging techniques.

Increasing Utilization Molecular Imaging

According to the nuclear medicine equipment market research report, molecular imaging is rapidly gaining momentum in the global market. This trend is primarily driven by the technology's capability to offer detailed analysis of molecular as well as cellular activity, which assists in early disease detection, especially in cardiology, oncology, and neurology. In addition, molecular imaging technologies are permitting more accurate diagnoses, supporting the overall customized treatment methods. For instance, in February 2024, researchers from the Radiological Society of North America developed a molecular imaging technology that offers high sensitivity for breast cancer detection with lowered chances of false positive results, i.e. 16% false positive rate in comparison to MRI's 62%. Moreover, as research continues to enhance the efficiency of radiopharmaceuticals leveraged in such procedures, the requirement for molecular imaging is anticipated to soar, establishing it as a critical trend in the market.

Heightened Adoption of Radiopharmaceuticals.

As per the nuclear medicine equipment market report, the amplifying adoption of radiopharmaceuticals is one of the key trends in the global market. Radiopharmaceuticals play a crucial role in therapeutic as well as diagnostic applications, especially for certain chronic disorders and cancer. Moreover, innovations in radiopharmaceutical development, such as lowered side effects and enhanced targeting agents, are improving the efficacy of nuclear therapy and imaging. In addition, healthcare providers are currently dependent of such compounds for treatment as well as diagnosis procedures, which is resultantly boosting the demand for nuclear medicine equipment that are efficient in leveraging such advanced agents. For instance, in August 2024, Eli Lily, a leading pharmaceutical company, announced its expansion in nuclear isotope production industry to secure a steady supply of radioactive compounds requisite for radiopharmaceutical oncology drugs. As an expansion strategy, the company invested USD 10 million into Ionetix, an isotope supplier.

NUCLEAR MEDICINE EQUIPMENT MARKET SEGMENTATION:

Breakup by Product:

  • Single-Photon Emission Computed Tomography
    • Standalone
    • Hybrid
  • Positron Emission Tomography
    • Standalone
    • Hybrid
  • Planar Scintigraphy

Single-photon emission computed tomography accounts for the majority of the market share

According to the nuclear medicine equipment market forecast, single-photon emission computed tomography (SPECT) is anticipated to sustain its dominance as the largest product segment. Standalone SPECT systems offer essential functional imaging, broadly leveraged in oncology, cardiology, and neurology. Whereas, hybrid SPECT systems merge both functional and anatomical imaging, providing enhanced diagnostics precision by offering more insightful images. Moreover, the incorporation of hybrid imaging systems in rapidly adopted, especially in complicated diagnostics conditions, further boosting market demand. In addition, the accuracy provided by hybrid SPECT systems is significantly fueling their adoption in emerging as well as developed healthcare markets. For instance, in March 2024, Spectrum Dynamics Medical announced the successful installation of its new, innovative, digital SPECT/CT VERITON-CT 400 at a European cancer center. It is a hybrid SPECT/CT that can efficiently detect and locate tumors in the body.

Breakup by Application:

  • Neurology
  • Oncology
  • Cardiology
  • Others

Oncology holds the largest share of the industry

As per the nuclear medicine equipment market overview, oncology represents the dominant application segment, majorly due to the increasing demand for nuclear imaging technologies such as SPECT and PET in cancer treatment as well as diagnosis. Such systems facilitate the early detection of cancerous tissues and the observation of treatment efficiency through accurate molecular imaging. In addition, the heightening prevalence of cancer worldwide, combined with advancements in radiopharmaceuticals and nuclear medicine, continues to bolster the demand for oncology-specific imaging equipment, establishing oncology as a major growth segment in the global nuclear medicine market. According to the World Health Organization, around 1 in 5 individuals are detected with cancer in their lifetime, while around 1 in 12 women and 1 in men die from this disease.

Breakup by End User:

  • Hospitals
  • Imaging Centers
  • Academic and Research Institutes
  • Others

Hospitals represent the leading market segment

Hospitals are the largest end-user segment that significantly contributes to the nuclear medicine equipment market revenue. As healthcare institutions with the robust infrastructure to maintain the sophisticated therapeutic and diagnostic procedures, hospitals rapidly dependent on cutting-edge imaging technologies such as PET and SPECT for precise treatment as well as diagnosis. In addition, the incorporation of nuclear medicine equipment into hospital ecosystem is requisite for enhancing patient care and outcome, especially in neurology, oncology, and cardiology. Moreover, the magnifying adoption of innovative nuclear imaging technologies and heightening investments in hospital-based imaging centers are bolstering growth within this crucial market segment.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest nuclear medicine equipment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nuclear medicine equipment.

North America has emerged as the leading regional market in, majorly driven by its robust healthcare infrastructure, early adoption of cutting-edge technologies and elevated healthcare expenditure. The United States, particularly, is at the forefront chiefly due to the high prevalence of chronic disorders such cardiovascular diseases and cancer, which accelerate the demand for nuclear imaging significantly. According to the National Cancer Institute, it is estimated that in 2024 total 2,001,140 new cancer cases will be diagnosed in the U.S., and around 611,720 individuals will die from this disease. In addition, government funds for research and development, coupled with the presence of key industry players, further fortifies North America's dominance in the global nuclear medicine equipment market.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nuclear medicine equipment industry include Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH, and Toshiba Corporation. ()
  • The market is represented by fierce competition among key companies such that are currently emphasizing on strategic acquisitions, partnerships, and product innovation, to sustain their market dominance. For instance, in June 2024, QEII Health Sciences Center of Nova Scotia Health acquired GE Healthcare's StarGuide SPECT/CT equipment. This was a USD 6 million project, co-funded by both Nova Scotia and QEII, and improves diagnostic accuracy for heart diseases and cancer. In addition, technological advancements in radiopharmaceutical development and hybrid imaging systems significantly fuel competition, as key players are actively striving to improve their diagnostic precision and enhance patient outcomes. The competitive landscape is further steered by elevating investments in research and technological innovations, consequently contributing to the optimistic nuclear medicine equipment market outlook.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global nuclear medicine equipment market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine equipment market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine equipment market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine equipment market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine equipment market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine equipment market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the nuclear medicine equipment market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global nuclear medicine equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Single-Photon Emission Computed Tomography
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Standalone
      • 6.1.2.2 Hybrid
    • 6.1.3 Market Forecast
  • 6.2 Positron Emission Tomography
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Standalone
      • 6.2.2.2 Hybrid
    • 6.2.3 Market Forecast
  • 6.3 Planar Scintigraphy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Imaging Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biodex Medical Systems Inc. (Mirion Technologies Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Cardinal Health Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CMR Naviscan Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 DDD-Diagnostic A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Digirad Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Mediso Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neusoft Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SurgicEye GmbH
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Toshiba Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nuclear Medicine Equipment Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Equipment Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Nuclear Medicine Equipment Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Nuclear Medicine Equipment Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Nuclear Medicine Equipment Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Nuclear Medicine Equipment Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Nuclear Medicine Equipment Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Nuclear Medicine Equipment (Neurology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Nuclear Medicine Equipment (Neurology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Nuclear Medicine Equipment (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Nuclear Medicine Equipment (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Nuclear Medicine Equipment (Cardiology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Nuclear Medicine Equipment (Cardiology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Nuclear Medicine Equipment (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Nuclear Medicine Equipment (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Nuclear Medicine Equipment (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Nuclear Medicine Equipment (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Nuclear Medicine Equipment (Imaging Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Nuclear Medicine Equipment (Imaging Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Nuclear Medicine Equipment (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Nuclear Medicine Equipment (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Nuclear Medicine Equipment Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Nuclear Medicine Equipment Industry: SWOT Analysis
  • Figure 80: Global: Nuclear Medicine Equipment Industry: Value Chain Analysis
  • Figure 81: Global: Nuclear Medicine Equipment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Equipment Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Nuclear Medicine Equipment Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Nuclear Medicine Equipment Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Equipment Market: Key Players